MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Demographic Influences on Wearing Off Symptoms in Parkinson’s Disease

L. Chahine, G. Cummin, S. Chen, J. Buchanich, B. Edison, M. Daeschler, S. Kahl, C. Kopil, C. Marras (Toronto, ON, Canada)

Meeting: 2019 International Congress

Abstract Number: 821

Keywords: Wearing-off fluctuations

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: To examine differences in wearing off symptoms in Parkinson’s Disease (PD) according to gender, age, and age at PD diagnosis.

Background: Off symptoms in PD have a significant negative impact on quality of life. “Wearing off”, or the emergence of symptoms as the effect of a given dose of PD medication wanes, is often treatable with adjustments in medications or surgical interventions. Thus, diagnosis of wearing off is essential. Unfortunately, this phenomenon may go undetected in many patients. Better understanding of how patients’ off symptoms manifest in different PD populations is important to improving their detection.

Method: This was a cross-sectional survey study administered through Fox Insight, an online observational study of PD. 13,359 individuals self-reported as having PD and taking levodopa were invited to complete the survey. The Wearing Off Questionnaire-19 (WOQ-19) assessed off symptoms and their medication-responsiveness. Differences in self-identified males vs. females were examined, as were wearing off symptoms in relation to age at survey and age at PD diagnosis.

Results: 2113 respondents completed the survey, 1011 (52%) females, mean age 66.6 years, median duration since diagnosis 5.0 years.  Females were 1 year younger at PD diagnosis compared to males (59.8 vs 60.8, p=0.017). Females reported a greater number of medication-responsive wearing off symptoms compared to males (5.4 vs. 4.9, p=0.003). Age at PD diagnosis (β=-0.009, p=0.034) and female gender (β=0.20, p=0.003) predicted non-motor symptom burden; only younger age at PD diagnosis predicted motor symptom burden (β=-0.057, p<0.001). Detailed analyses of wearing off symptom profiles according to demographic and disease characteristics will be presented.

Conclusion: Non-motor wearing off symptom burden varies according to age at PD diagnosis and gender. Symptom complex patterns in men and women with wearing off differ. An awareness of this will help in identification and management of off symptoms in PD.

To cite this abstract in AMA style:

L. Chahine, G. Cummin, S. Chen, J. Buchanich, B. Edison, M. Daeschler, S. Kahl, C. Kopil, C. Marras. Demographic Influences on Wearing Off Symptoms in Parkinson’s Disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/demographic-influences-on-wearing-off-symptoms-in-parkinsons-disease/. Accessed July 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/demographic-influences-on-wearing-off-symptoms-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley